22-Apr-2026      09:22

Ajanta Pharma's Paithan unit concludes USFDA inspection

Ajanta Pharma announced that the USFDA has concluded an inspection at its manufacturing facility at Paithan, in Maharashtra. The Inspection was conducted from 13 April 2026, to 21 April 2026, and closed with the issuance of Form-483 with 5 (five) observations.

News source: Capital Market - Live News